Complete Response for More than 4 Years following Neoadjuvant FOLFOX and Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Patient with Advanced Gastric Cancer with Extensive Peritoneal Carcinomatosis

BACKGROUND: Peritoneal carcinomatosis is usually a terminal disease with short median survival in patients with gastric cancer. Systemic FOLFOX is one of the most used regimens in the first-line treatment of metastatic gastric cancer. However, there is scarce evidence that cytoreductive surgery (CRS...

Descripción completa

Detalles Bibliográficos
Autores principales: Peixoto, Renata D'Alpino, de Sousa, Tercia Tarciane, Silva, Pedro Alexandre Ismael Amaral, de Meirelles, Luciana Rodrigues, Teixeira, Carlos Henrique Andrade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006599/
https://www.ncbi.nlm.nih.gov/pubmed/29928208
http://dx.doi.org/10.1159/000488978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006599/
https://www.ncbi.nlm.nih.gov/pubmed/29928208
http://dx.doi.org/10.1159/000488978

Ejemplares similares